P3 Health Partners Inc.

PIII Nasdaq SEC CIK 1832511
Follow P3 Health Partners Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $396.3M +14.8% vs same quarter last year
Net income $15.6M +149.5% vs same quarter last year
EPS, diluted $0.07 +100.7% vs same quarter last year
Operating cash flow −$685K +95.6% vs same quarter last year
Revenue by quarter
$370.7M
$373.2M
$355.8M
$345.3M
$384.8M
$386.4M
$386.4M
$396.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5B$2BFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.5B−$147.9M
FY24$1.5B−$135.8M
FY23$1.3B−$57.8M
FY22$1B−$270.1M
FY21--
FY20$491.1M−$31.4M
FY19$145.5M−$42M
MarginsShare of revenue
  • Operating margin
  • Net margin
−150%−100%−50%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−18.5%−10.1%
FY24−21.4%−9.1%
FY23−13.3%−4.6%
FY22−148.7%−25.7%
FY21--
FY20−5.8%−6.4%
FY19−27.2%−28.8%
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$110.1M
FY23−$77.9M
FY22−$128.3M
FY21-
FY20−$27.5M
FY19−$29.7M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • P3 Health Partners
  • Healthcare median
−100%−75%−50%−25%0%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearP3 Health PartnersHealthcare median
FY25−10.1%−30.6%
FY24−9.1%−47%
FY23−4.6%−58%
FY22−25.7%−80.4%
FY21-−71.9%
FY20−6.4%−62.2%
FY19−28.8%−46.3%